Efficacies of Colistin–Carbapenem versus Colistin–Tigecycline in Critically Ill Patients with CR-GNB-Associated Pneumonia: A Multicenter Observational Study

Efficacies of Colistin–Carbapenem versus Colistin–Tigecycline in Critically Ill Patients with CR-GNB-Associated Pneumonia: A Multicenter Observational Study

<b>Background:</b> Evaluating the options for antibiotic treatment for carbapenem-resistant Gram-negative bacteria (CR-GNB)-associated pneumonia remains crucial. We compared the therapeutic efficacy and nephrotoxicity of two combination therapies, namely, colistin + carbapenem (CC) versu...

Full description

Bibliographic Details
Main Authors: Sheng-Huei Wang, Kuang-Yao Yang, Chau-Chyun Sheu, Wei-Cheng Chen, Ming-Cheng Chan, Jia-Yih Feng, Chia-Min Chen, Biing-Ru Wu, Zhe-Rong Zheng, Yu-Ching Chou, Chung-Kan Peng, on behalf of the T-CARE (Taiwan Critical Care Infection) Group
Format: Article
Language:English
Published: MDPI AG 2021-09-01
Series:Antibiotics
Subjects:
carbapenem resistant
colistin
tigecycline
pneumonia
nephrotoxicity
Online Access:https://www.mdpi.com/2079-6382/10/9/1081

Internet

https://www.mdpi.com/2079-6382/10/9/1081

Similar Items